Simplex Trading
RXRX icon

Simplex Trading’s Recursion Pharmaceuticals RXRX Stock Holding History

Simplex Trading’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$440K Buy
+143,300
New +$554K ﹤0.01% 3418
2025
Q4 		– Sell
-161,900
Closed -$790K – 9864
2025
Q3 		$790K Sell
161,900
-241,700
-60% -$1.27M ﹤0.01% 3292
2025
Q2 		$2.04M Buy
403,600
+8,800
+2% +$43.2K ﹤0.01% 2087
2025
Q1 		$2.09M Sell
394,800
-95,000
-19% -$693K ﹤0.01% 1994
2024
Q4 		$3.31M Buy
489,800
+96,800
+25% +$651K ﹤0.01% 1779
2024
Q3 		$2.59M Buy
393,000
+118,000
+43% +$846K ﹤0.01% 2057
2024
Q2 		$2.06M Buy
275,000
+31,800
+13% +$277K ﹤0.01% 2171
2024
Q1 		$2.42M Buy
243,200
+190,200
+359% +$2.12M ﹤0.01% 2208
2023
Q4 		$522K Sell
53,000
-93,900
-64% -$670K ﹤0.01% 3657
2023
Q3 		$1.12M Buy
146,900
+139,200
+1,808% +$1.39M ﹤0.01% 2551
2023
Q2 		$57K Buy
7,700
+6,000
+353% +$42K ﹤0.01% 5717
2023
Q1 		$11K Sell
1,700
-400
-19% -$3.17K ﹤0.01% 7481
2022
Q4 		$16K Sell
2,100
-7,000
-77% -$68.6K ﹤0.01% 7100
2022
Q3 		$96K Sell
9,100
-2,200
-19% -$22.3K ﹤0.01% 5593
2022
Q2 		$91K Buy
11,300
+2,200
+24% +$14.7K ﹤0.01% 5694
2022
Q1 		$65K Buy
9,100
+6,800
+296% +$72.3K ﹤0.01% 6774
2021
Q4 		$39K Buy
+2,300
New +$43.3K ﹤0.01% 7573

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's RXRX Position: Q1 2026 in Review

Simplex Trading opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 97,118 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #3826 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RXRX as recently as Q1 2025.

Simplex Trading first reported a position in RXRX in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.54M in Q1 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Simplex Trading held 97,118 shares of Recursion Pharmaceuticals worth $298K as of Q1 2026.
  • Recursion Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3826 holding.
  • Simplex Trading first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • Simplex Trading's Recursion Pharmaceuticals position peaked at $2.54M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.